Context Therapeutics Analyst Ratings
Context Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/07/2023 | 316.62% | HC Wainwright & Co. | → $4 | Reiterates | → Buy |
| 02/02/2022 | 524.93% | HC Wainwright & Co. | → $6 | Initiates Coverage On | → Buy |
| 01/24/2022 | 941.56% | ThinkEquity | → $10 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 02/07/2023 | 316.62% | HC 溫賴特 & 有限公司. | → 4 美元 | 重申 | → 購買 |
| 2022 年 2 月 2 日 | 524.93% | HC 溫賴特 & 有限公司. | → 6 美元 | 啟動覆蓋範圍 | → 購買 |
| 2022 年 1 月 24 日 | 941.56% | 思想 | → 10 美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for Context Therapeutics (CNTX)?
上下文治療（CNTX）的目標價格是多少？
The latest price target for Context Therapeutics (NASDAQ: CNTX) was reported by HC Wainwright & Co. on February 7, 2023. The analyst firm set a price target for $4.00 expecting CNTX to rise to within 12 months (a possible 316.62% upside). 1 analyst firms have reported ratings in the last year.
HC 溫賴特有限公司於 2023 年 2 月 7 日報導了上下文治療（納斯達克代碼：CNTX）的最新價格目標。該分析師公司設定了 4.00 美元的價格目標，預計 CNTX 將在 12 個月內上升（可能是 316.62％ 的上漲）。1 家分析師公司在去年報告了評級。
What is the most recent analyst rating for Context Therapeutics (CNTX)?
上下文治療（CNTX）的最新分析師評級是什麼？
The latest analyst rating for Context Therapeutics (NASDAQ: CNTX) was provided by HC Wainwright & Co., and Context Therapeutics reiterated their buy rating.
上下文治療（納斯達克：CNTX）的最新分析師評級由 HC Wainwright & Co. 提供，上下文治療重申了他們的購買評級。
When is the next analyst rating going to be posted or updated for Context Therapeutics (CNTX)?
什麼時候會針對上下文治療 (CNTX) 公佈或更新下一個分析師評級？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Context Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Context Therapeutics was filed on February 7, 2023 so you should expect the next rating to be made available sometime around February 7, 2024.
分析師在進行廣泛的研究後獲得股票評級，其中包括通過公共財務報表，與 Context Theraptive 的高管和客戶交談以及收聽盈利電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。上下文治療的最後評級已於 2023 年 2 月 7 日提交，因此您應該期望下一個評分將在 2024 年 2 月 7 日左右提供。
Is the Analyst Rating Context Therapeutics (CNTX) correct?
分析師評級上下文治療（CNTX）是否正確？
While ratings are subjective and will change, the latest Context Therapeutics (CNTX) rating was a reiterated with a price target of $0.00 to $4.00. The current price Context Therapeutics (CNTX) is trading at is $0.96, which is within the analyst's predicted range.
儘管評級是主觀的並且會發生變化，但最新的上下文治療（CNTX）評級重申，目標價格為 0.00 美元至 4.00 美元。當前價格上下文治療（CNTX）的交易價格為 0.96 美元，該價格在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。